García-Juárez A, Hernández MA, Burgos-Franco KG, Flores-González N, García-Moreno S

Language: Spanish
References: 20
Page: 635-640
PDF size: 376.00 Kb.

ABSTRACT

Objective: To investigate the prevalence of rheumatic illnesses that required admission to the emergency department from January 2011 to December 2012.
Material and methods: A retrospective study was performed with the records of the Emergency Room to identify the most common rheumatic illnesses.
Results: In 2011 were admitted to the emergency room 18,210 patients, 35 of them with rheumatic illnesses: 11 with lupus and 8 with rheumatoid arthritis, the mean age was 51.6 years. In 2012 were admitted to the emergency room 15,866 patients, 20 of them with rheumatic illnesses: 7 with lupus and 3 with rheumatoid arthritis, the mean age was 46.3 years. Females were the most affected.
Conclusion: From 2011 to 2012 only 55 cases of rheumatic illness were registered. The rheumatic illnesses implying the highest risk for life are systemic lupus erythematosus and rheumatoid arthritis.

REFERENCES

1. Doornum VS, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2061-2068.

2. Panopalis P, Gillis ZJ, Yazdany J, Trupin L, et al. Frequent use of the emergency department among persons with systemic lupus erythematosus. Arthritis Care Research 2010;62:401-408.

3. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit: causes of consultation, hospitalization and outcome. A cohort study. Lupus 2000;9:601-606.

4. Issacs DJ, Greer S, Sharma S, Symmons D, et al. Morbidity and mortality in rheumatoid arthritis with prolonged and profound therapy-induce lymphopenia. Arthritis Rheumatism 2001;44:1998-2008.

5. Pryor DB, Bologna GS, Kahl L. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-1482.

6. Bernatsky S, Boivin FJ, Manzi J, Joseph L, Ginzler E. Mortality in systemic lupus erythematosus. Arthritis Rheumatism 2006;54:2550-2557.

7. Perina GD, Brunett PC, Caro AD, Char MD, et al. The 2011 model of the clinical practice of emergency medicine. Acad Emerg Med 2012;19:19-40.

8. McCarthy ME, Sheane JB, Cunnane G. Greater focus on clinical rheumatology is required for training in internal medicine. Clin Rheumatol 2009;28:139-143.

9. Puolakka K, Kautiainen H, Möttonen T, Hannonen P, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis. Arthritis Rheuma 2005;52:36-41.

10. Panopalis P, Gillis ZJ, Yazdany J, Trupin L, et al. Frequent use of the emergency department among persons with systemic lupus erythematosus. Arthritis Care Research 2010;62:401-408.

11. Panopalis P, Yazdany J, Gillis ZJ, Trupin L, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Artritis Care Research 2008;59:1788-1795.

12. Williams FK, Chinn S, Hughes GRV, Leach RM. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 2002;61:414-421.

13. Westlake LS, Colebatch NA, Baird J, Kiely P, et al. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systemic literature review. Rheumatology 2010;49:295-307.

14. Dornum SV, Brand C, King B, Sundarajan V. Increased case fatality rates following a first cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2061-2068.

15. Hootman MJ, Helmick GC, Schappert MS. Magnitude and characteristics of arthritis and other rheumatic condition on ambulatory medical care visits. United States, 1997. Arthritis Care Research 2002;47:571-581.

16. Slobodin G, Hussein A, Rozenbaum M, Rosner I. The emergency room in systemic rheumatic diseases. Emerg Med J 2006;23:667-671.

17. Ward MM. Association between physician volume and in-hospital mortality in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:1646-1654.

18. Clarke EA, Estaidle MJ, Bloch AD, Lacaile B, et al. A Canadian study of the total medical costs for patients with systemic lupus erythematous and predictors of costs. Arthritis Rheum 1993;36:1548-1559.

19. Van Leuven SI, Franssen R, Kaltelein JJ, Levi M, et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008;47:3-7.

20. Weckerle EC, Franek SB, Kelley AJ, Kumabe M, et al. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 2011;63:1044- 1053.